AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma3/11/2010 10:03:00 PM
FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer3/11/2010 9:15:00 PM
Trubion to Present Company Overview and Participate in Panel Discussion at Prestigious Life Science Innovation Northwest 20103/11/2010 9:00:00 PM
Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer3/11/2010 8:08:00 PM
Volcano Announces Activities at the ACC 20103/11/2010 8:00:00 PM
bioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool3/11/2010 7:03:00 PM
Stimuvax Will Become Decision Resources' Proprietary Clinical Gold Standard For The Treatment Of Locally Advanced Non-Small-Cell Lung Cancer3/11/2010 3:30:00 PM
Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elan3/11/2010 3:19:00 PM
Newly-Published Study Reinforces Role of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) as an Add-on Treatment that Significantly Reduces Partial-onset Seizures in Adults with Epilepsy3/11/2010 2:05:00 PM
Athena Feminine Technologies, Inc. Initiates Enrollment of Phase IV Clinical Trial for Athena Pelvic Muscle Trainer(TM)3/11/2010 2:00:00 PM
CBio Secures Another Clinical Trial Milestone3/11/2010 2:00:00 PM
Leading Varian-Equipped Proton Therapy Center Treats 100th Patient3/11/2010 1:00:00 PM
Frost & Sullivan Lauds Positron Corporation for Cardiac-Focused PET Molecular Imaging Scanner Attrius(TM)3/11/2010 12:45:00 PM
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter Fiscal Year 20103/11/2010 12:00:00 PM
Pulmonary Fibrosis Patient Organizations Applaud Efforts of Patients, Families at FDA Hearing3/10/2010 8:49:00 PM
Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says3/10/2010 8:02:00 PM
Smith & Nephew Announces Next Steps in Patent Infringement Litigation3/10/2010 6:39:00 PM
CEL-SCI Receives Payment From Marketing Partner3/10/2010 3:30:00 PM
Research Findings Expected to Ease Treatment of Low Neutrophil Counts in Cancer Patients3/10/2010 3:10:00 PM
Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results3/10/2010 1:38:00 PM
Experts here are available to answer all your questions!
